News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,001 Results
Type
Article (20077)
Company Profile (150)
Press Release (346774)
Section
Business (114930)
Career Advice (966)
Deals (23119)
Drug Delivery (93)
Drug Development (52910)
Employer Resources (79)
FDA (8260)
Job Trends (8562)
News (203247)
Policy (18621)
Tag
Academia (781)
Alliances (30551)
Alzheimer's disease (649)
Approvals (8249)
Artificial intelligence (88)
Bankruptcy (207)
Best Places to Work (6300)
Biosimilars (71)
Biotechnology (71)
Breast cancer (86)
Cancer (755)
Cardiovascular disease (71)
Career advice (792)
Cell therapy (116)
Clinical research (43775)
Collaboration (285)
Compensation (99)
COVID-19 (1109)
Data (831)
Diabetes (115)
Diagnostics (2252)
Drug pricing (98)
Earnings (41812)
Employer resources (73)
Events (53465)
Executive appointments (272)
FDA (8630)
Funding (225)
Gene therapy (97)
GLP-1 (514)
Government (1902)
Healthcare (7113)
Infectious disease (1165)
Inflammatory bowel disease (77)
Interviews (132)
IPO (10266)
Job creations (2518)
Job search strategy (714)
Layoffs (256)
Legal (4558)
Lung cancer (115)
Manufacturing (154)
Medical device (3541)
Medtech (3544)
Mergers & acquisitions (13010)
Metabolic disorders (379)
Neuroscience (857)
NextGen Class of 2024 (2918)
Non-profit (1019)
Northern California (842)
Obesity (238)
Opinion (179)
Patents (93)
People (35468)
Pharmaceutical (78)
Phase I (13685)
Phase II (18709)
Phase III (14784)
Pipeline (341)
Policy (74)
Postmarket research (1631)
Preclinical (4894)
Radiopharmaceuticals (172)
Rare diseases (173)
Real estate (3437)
Regulatory (13011)
Research institute (889)
Resumes & cover letters (147)
Southern California (814)
Startups (2245)
United States (8110)
Vaccines (228)
Weight loss (199)
Date
Today (2)
Last 7 days (245)
Last 30 days (1305)
Last 365 days (20055)
2024 (19992)
2023 (22513)
2022 (29133)
2021 (30622)
2020 (28859)
2019 (22944)
2018 (17782)
2017 (19130)
2016 (17770)
2015 (21028)
2014 (16334)
2013 (13804)
2012 (14880)
2011 (14940)
2010 (13834)
Location
Africa (410)
Arizona (70)
Asia (26173)
Australia (3404)
California (1993)
Canada (894)
China (198)
Colorado (79)
Connecticut (86)
Europe (52618)
Florida (295)
Illinois (200)
Indiana (141)
Maryland (292)
Massachusetts (1604)
Michigan (88)
Minnesota (109)
New Jersey (744)
New York (633)
North Carolina (485)
Northern California (842)
Ohio (72)
Pennsylvania (462)
South America (633)
Southern California (814)
Texas (282)
Washington State (184)
367,001 Results for "camino pharma llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Camino Pharma receives $1.97M Small Business Innovation Research (SBIR) Grant from the National Institute of Alcohol Abuse and Alcoholism
Camino Pharma, LLC announced that its co-founder and CSO, Reto Gadient, Ph.D., has been awarded a two-year, $1.97M grant by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number U43AA031388 and is the Principal Investigator on the grant.
December 7, 2023
·
4 min read
Press Releases
Boston Institute of Biotechnology, LLC with BiBo Pharma Announce Groundbreaking Expansion to Revolutionize Global Biologics Production Capacity
December 20, 2024
·
3 min read
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.
January 10, 2024
·
1 min read
Biotech Beach
$9 million NIH grant advances drug to treat nicotine addiction
Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California San Diego School of Medicine received a $9-million grant from the National Institute on Drug Abuse at the National Institutes of Health.
February 6, 2024
·
5 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
FSD Pharma Provides Corporate Update - May 24, 2024
FSD Pharma Inc. is pleased to announce that it has entered into an investor relations services agreement with IR Agency LLC effective May 22, 2024.
May 24, 2024
·
7 min read
1 of 36,701
Next
